Nan Shan Life Insurance Co., Ltd. Biogen Inc. Transaction History

Nan Shan Life Insurance Co., Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$258.66 - $342.55 $1.81 Million - $2.4 Million	-7,000 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$220.06 - $304.07 $1.54 Million - $2.13 Million	7,000 New	7,000 $2.08 Million
Q3 2016 Jun 20, 2018	SELL	N/A	-52,800 Closed	0 $0
Q3 2015 Jun 20, 2018	BUY	N/A	10,000 Added 23.36%	52,800 $15.4 Million
Q2 2015 Jun 20, 2018	BUY	N/A	42,800	42,800 $17.3 Million

1,038

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $22.5B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Nan Shan Life Insurance Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on Nan Shan Life Insurance Co., Ltd. with notifications on news.